IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Darwin Global Management, Ltd.

Q1 2023 Holdings

Filed 2023-05-15 | 4 holdings | $365.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
TG Therapeutics Inc(TGTX)COM88322Q108$157.2M10,451,24143.0%
Argenx SE(ARGX)SPONSORED ADR04016X101$106.3M285,19829.1%
Ambrx Biopharma IncSPONSORED ADS02290A102$100.8M11,304,57327.6%
Keros Therapeutics Inc(KROS)COM492327101$1.3M31,3860.4%